Different Pharma Companies Product Pipeline Reviews by Global Markets Direct Now Available at MarketPublishers.com

08 Jan 2015 • by Natalie Aster

LONDON – Market Publishers Ltd announces that Global Markets Direct reports on different pharma firms’ R&D focus have been added to its catalogue.

These topical research reports provide overviews of the various pharmaceutical companies’ research and development focus. Each study contains detailed information on the current clinical developmental pipeline of the pertinent firm, supplemented with a comparative analysis at different stages, therapeutics assessment by RoA, MoA, drug target, and molecule type. The insightful reviews of the latest updates, and featured press releases and news, alongside details of projects, late-stage and discontinued, are at hand in each company review as well.

Company Reports List Includes but Is Not Limited To:

Each Report Scope:

  • Brief overview of the company under consideration, including the description of the business, essential information and key facts, as well as its locations and subsidiaries.
  • Overview of the current pipeline of the firm’s human therapeutic division, enlisting all of their projects, major and minor like.
  • Granular product description and a review of the descriptive MoA for major pipeline products in tandem with the product’s background and prominent milestones.
  • Special information on portfolio of partnered and out-licensed products.
  • Summary of all of the discontinued and dormant pipeline projects.
  • Latest up-to-the-minute company statement.
  • Most recent news and deals pertaining to the company’s products in development.

More company profiles and other studies by the publisher can be found at Global Markets Direct page

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com 
MarketPublishers.com